Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.653
Abstract: 653Background: PI3K pathway is a known modulator of anti-tumor immune response and is frequently activated in CRC through genetic alterations such as PTEN loss (PTENloss) and PIK3CA mutations (PIK3...
read more here.
Keywords:
pathway activation;
kinase pi3k;
association phosphatidylinositol;
activation increased ... See more keywords